Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs First Citizens BancShares Inc (FCNCA) Price & Performance

Cronos Group IncTrade
First Citizens BancShares IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs First Citizens BancShares Inc — how do they compare? Cronos Group Inc trades at $2.75 (market cap $1.02B), while First Citizens BancShares Inc trades at $2,056.42 (market cap $23.65B). The key difference: First Citizens BancShares Inc is far larger — about 23.2× Cronos Group Inc's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.

CRONFCNCA
Market Cap
$1.02B$23.65B
Sector
HealthSector/Thematic
52-Week High
$3.27$2.20K
52-Week Low
$1.95$1.64K
Enterprise Value
$203.29M
Dividend Yield
0.41%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $2.75, showing no change recently. The stock has a mixed technical outlook with a neutral overall signal but bullish moving averages. Fundamentally, revenue grew to $146.59M in 2025, but net income was negative at -$9.45M. Recent news highlights strong Q1 2026 revenue growth of 40% and expansion of its Spinach brand portfolio, though the company faces intense cannabis sector competition.

Outlook is cautious with growth potential from international expansion and market share gains, but profitability remains a challenge. Risks include regulatory uncertainty and competitive pressures. Analyst sentiment is mixed with 60% hold ratings. The stock presents a speculative opportunity for investors betting on continued top-line growth and eventual margin improvement.

First Citizens BancShares Inc

First Citizens BancShares (FCNCA) trades at $2,106.06, up 0.64% with a bullish technical outlook and strong fundamental performance. The stock shows consistent earnings beats, with Q1 2026 EPS of $44.86 exceeding expectations by 13.4%. Recent developments include expansion of commercial banking capabilities and the planned retirement of the Silicon Valley Bank brand name in Q4 2026. The company maintains solid profitability with a 24.35% net income margin and 10.5% ROE, supported by $9.25B in revenue for 2025.

FCNCA presents a mixed investment case with strong fundamentals but cautious analyst sentiment. While valuation appears reasonable at 11.89 P/E and 1.18 P/B ratios, the majority of analysts (81.82%) maintain Hold ratings. Key opportunities include continued earnings momentum and strategic brand alignment, while risks involve margin pressure and credit exposure in the tech sector. The consensus price target of $2,320 suggests modest upside potential from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA